Endo International plc’s subsidiary Endo Ventures Limited (EVL) has acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables Inc., a subsidiary of Nevakar Inc.   “These six product candidates that would be used in critical care settings meaningfully expand Endo’s ready-to-use injectable product pipeline,” said Scott Sims, senior vice president and general manager, Injectable Solutions & Generics at Endo. “We look forward to...